Creative Planning Sarepta Therapeutics, Inc. Put Options Transaction History
Creative Planning
- $103 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
515Shares Held
86.3MCall Options Held
1.49MPut Options Held
1.26M-
Black Rock Inc. New York, NY10.3MShares$657 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$577 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$575 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$276 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$259 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.57B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...